513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
N-able said on November 20, 2024 that it completed its acquisition of Adlumin, Inc., a cybersecurity company that provides extended detection and response and managed detection and response services. The company paid $100 million in cash and 1,570,762 shares of its common stock at closing, with additional deferred cash and up to $30 million in earn-out payments tied to performance targets. The filing also gave updated fourth-quarter and full-year 2024 revenue and adjusted EBITDA outlooks.
Closed November 20, 2024: about $100 million in cash, subject to customary adjustments, plus 1,570,762 shares of common stock
Deferred cash of $120 million, paid as $52.5 million and $67.5 million on the first and second anniversaries of closing
Up to $30 million in earn-out payments in 2025 and 2026 based on performance metrics
Full-year 2024 total revenue outlook of $463.0 million to $464.5 million, representing 10% year-over-year growth; fourth-quarter revenue outlook of $113.3 million to $114.8 million
Maximus reported fiscal 2024 revenue of $5.31 billion, up 8.2% from $4.90 billion, and diluted earnings per share of $4.99, up from $2.63. The company also set fiscal 2025 guidance calling for revenue of $5.275 billion to $5.425 billion and adjusted diluted EPS of $5.70 to $6.00, and declared a $0.30 quarterly dividend.
FY2024 revenue rose 8.2% to $5.31 billion; organic growth was 8.8%
FY2024 diluted EPS was $4.99 versus $2.63; adjusted diluted EPS was $6.11 versus $3.83
FY2025 guidance: revenue of $5.275 billion to $5.425 billion; adjusted diluted EPS of $5.70 to $6.00
Quarterly dividend of $0.30 per share payable November 30, 2024, to holders of record on November 15, 2024
Acadia Pharmaceuticals said Executive Vice President, Chief Operating Officer and Head of Commercial Brendan Teehan was involuntarily terminated without Cause, effective immediately. Mr. Teehan will stay on as a non-executive employee through December 31, 2024 to help transfer his duties to a successor, and CEO Catherine Owen Adams will assume his responsibilities until one is appointed.
Brendan Teehan's executive role ended effective immediately, per an agreement dated November 18, 2024
Teehan remains a non-executive employee until December 31, 2024 to assist with the transition
CEO Catherine Owen Adams will assume his responsibilities until a successor is appointed
The filing does not name a successor or state the reason for the termination
Assurant named Kevin Warren, former chief marketing and customer experience officer at UPS, to its Board of Directors and its Compensation and Talent Committee, effective January 15, 2025, subject to customary regulatory approval. Two directors are also leaving the board: Lawrence V. Jackson will retire at the 2025 annual meeting, and Paget L. Alves will resign effective January 15, 2025 to become CEO of Sorenson.
Kevin Warren joins the board and Compensation and Talent Committee effective January 15, 2025, subject to customary regulatory approval.
Warren served as chief marketing and customer experience officer at UPS from 2018 to 2024 and spent 34 years at Xerox Corporation.
Lawrence V. Jackson retires effective at the 2025 annual meeting of stockholders.
Paget L. Alves resigns from the board effective January 15, 2025 to become CEO of Sorenson.
Universal Technical Institute reported fiscal 2024 fourth-quarter and full-year results, with revenue and net income both higher than the prior year. The company also set fiscal 2025 guidance calling for revenue of $800-815 million and net income of $52-56 million, which would be increases over fiscal 2024 results. Adjusted free cash flow guidance of $58-62 million is below the $73.5 million reported for fiscal 2024, and beginning in fiscal 2025 growth investments will no longer be added back to Adjusted EBITDA.
Fourth-quarter revenue rose 15.3% to $196.4 million; net income was $18.8 million versus $6.7 million a year earlier.
Fiscal 2024 revenue was $732.7 million, up 20.6%, and net income was $42.0 million; diluted EPS was $0.75 versus $0.13.
Fiscal 2025 guidance: revenue $800-815 million, net income $52-56 million, diluted EPS $0.93-1.01, Adjusted EBITDA $120-124 million.
Fiscal 2025 adjusted free cash flow guidance is $58-62 million, down from $73.5 million in fiscal 2024, and assumes about $55 million of total capex.
On November 18, 2024, Merchants Bancorp agreed with a group of underwriters to sell 9.2 million depositary shares, each representing a 1/40th interest in its 7.625% Series E non-cumulative perpetual preferred stock, with a $25 liquidation value per depositary share. The company expects to use the net proceeds to redeem its Series B preferred stock and for general corporate purposes, including supporting balance sheet growth at Merchants Bank, with closing expected November 25, 2024.
9,200,000 depositary shares offered, each with a $25 liquidation value and a 1/40th interest in a Series E preferred share
Dividends at 7.625% per annum, payable quarterly when declared by the board, starting January 1, 2025
Offering expected to close on or about November 25, 2024; proceeds to redeem Series B preferred stock and for general corporate purposes
Wingstop and its subsidiaries signed a purchase agreement on November 19, 2024, under which a special purpose subsidiary will issue and sell $500 million of Series 2024-1 5.858% Fixed Rate Senior Secured Notes, Class A-2, in a private securitization. The closing is expected on December 3, 2024, subject to closing conditions, and the notes carry an anticipated repayment date in December 2031 with a legal final maturity in December 2054.
$500 million of Series 2024-1 5.858% Fixed Rate Senior Secured Notes, Class A-2, to be issued by Wingstop Funding LLC
Anticipated repayment date in December 2031; legal final maturity in December 2054
If not repaid or refinanced by the anticipated repayment date, additional interest accrues at the greater of 5.00% per annum and a Treasury-based formula plus 5.00% and 1.60%
Closing expected Tuesday, December 3, 2024; Morgan Stanley & Co. LLC and Barclays Capital Inc. are the initial purchasers
Williams-Sonoma reported third-quarter 2024 results for the quarter ended October 27, 2024. Net revenues fell to $1.80 billion from $1.85 billion and comparable brand revenue declined 2.9%, but diluted EPS rose 7.1% to $1.96 on an operating margin of 17.8%, and the company raised its full-year 2024 outlook. The board also approved a new $1 billion stock repurchase authorization, and the raised margin guidance includes a $49 million out-of-period freight expense adjustment.
Net revenues were $1.80 billion versus $1.85 billion a year earlier; comparable brand revenue fell 2.9%.
Diluted EPS was $1.96 versus $1.83; operating margin was 17.8% versus 17.0%.
Full-year 2024 net revenue decline is now expected at -3.0% to -1.5%, and operating margin at 18.4% to 18.8%, including a $49 million out-of-period adjustment.
A new $1 billion stock repurchase authorization was approved in September 2024; total authorization is $1.3 billion, including $293 million remaining under the March 2024 program.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.